Latest Strategy Changes News

Reliance Worldwide Corporation reported a 4.6% revenue decline and a 34.9% drop in net profit for H1 FY2026, citing US tariffs and weaker demand in key markets. The company balances challenges with cost savings and a shareholder-friendly capital return strategy.

HealthCo Healthcare & Wellness REIT posted solid half-year results amid ongoing efforts to resolve the Healthscope hospital portfolio situation, maintaining strong operational metrics and capital discipline.

HealthCo Healthcare and Wellness REIT posted a $26.8 million net loss for the half-year ended December 2025, driven by asset sales and fair value declines. The REIT suspended distributions and reduced its property portfolio as it navigates tenant risks and debt refinancing.

BPH Energy has successfully raised $0.54 million by issuing over 542 million new listed options, allowing existing option holders to maintain their stake in the company’s future.

Qualitas Limited reports robust interim results for the six months to December 2025, driven by strong deployment and expanding investor mandates, reaffirming its FY26 guidance.

Qualitas Limited has delivered a standout first half of FY26, posting a 30% rise in normalised net profit before tax and record investment deployment, reinforcing its position in Australia’s alternative investment sector.

PEXA Group has announced its strategic exit from majority-owned Digital Solutions businesses, triggering a $26 million impairment and a restatement of its FY26 financial guidance. The move signals a sharper focus on core operations amid restructuring costs.

Qualitas Real Estate Income Fund reported a robust 33.7% increase in net assets to over $1 billion and a 5% rise in operating profit for the half-year ended December 2025, driven by strategic capital raisings and strong portfolio management.

Praemium Limited is undertaking a major restructure of its technology division following its acquisition of Technotia Laboratories, aiming to streamline operations and reduce costs while enhancing technological capabilities.

Vita Life Sciences has reported a strong FY2025 with record revenue of $93.3 million and net profit after tax rising 18.8%, while declaring a 14.0 cents per share dividend.

H&G High Conviction Limited has significantly reduced its half-year loss following asset divestment and is actively exploring strategic alternatives to enhance shareholder value amid looming ASX re-compliance requirements.

Simonds Group Limited has reported a robust 1H FY26 performance with a 14% revenue increase and strategic entry into Western Australia, signalling confidence in sustained growth.